Finance
GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
Feb 25 (Reuters) - GSK on Wednesday agreed to pay $950 million in cash for Canadian biopharmaceutica...
25th February, 2026
healthcare
Latest articles
Finance
Eye-care group Alcon expects product launches to drive 2026 sales, profitability
Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates...
25th February, 2026
Finance
Sensodyne maker Haleon forecasts below-target 2026 growth on weak demand in US
Feb 25 (Reuters) - British consumer healthcare group Haleon reported a slowdown in fourth‑quarter re...
25th February, 2026
Finance
Healthcare group Fresenius' 2026 outlook falls short of expectations
Feb 25 (Reuters) - German healthcare group Fresenius narrowly beat analysts' expectations for fourth...
25th February, 2026
Finance
Novo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027
COPENHAGEN, Feb 24 (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday it plans to slash the U...
24th February, 2026
Finance
Novo Nordisk to halve US list price of Wegovy from 2027
Feb 24 (Reuters) - Danish drugmaker Novo Nordisk plans to slash U.S. list prices of its blockbuster...
24th February, 2026
Finance
UK medical products maker Convatec lifts medium‑term revenue growth target
Feb 24 (Reuters) - Convatec lifted its medium-term organic revenue growth target on Tuesday, citing...
24th February, 2026
Finance
Fresenius Medical Care's meek 2026 guidance sends shares falling
Feb 24 (Reuters) - Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income o...
24th February, 2026
Finance
Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugs
By Maggie Fick and Bhanvi Satija LONDON, Feb 24 (Reuters) - With U.S. arch rival Eli Lilly streaking...
24th February, 2026
Finance
Italian region resists US pressure to curb use of Cuban doctors
By Crispian Balmer ROME, Feb 23 (Reuters) - Cuban doctors are essential to keeping local hospitals r...
23rd February, 2026
Finance
Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death
BERLIN, Feb 23 (Reuters) - German pharmaceutical company Bayer said on Monday that it had filed a la...
23rd February, 2026
Finance
Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say
Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than...
23rd February, 2026